SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MANFRINATO, Maria Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.866
AS - Asia 3.531
EU - Europa 1.995
SA - Sud America 553
AF - Africa 90
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 12.050
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.744
SG - Singapore 1.310
CN - Cina 956
BR - Brasile 419
VN - Vietnam 407
IT - Italia 325
DE - Germania 315
UA - Ucraina 315
HK - Hong Kong 272
GB - Regno Unito 229
FI - Finlandia 165
TR - Turchia 165
PL - Polonia 121
FR - Francia 111
RU - Federazione Russa 97
JP - Giappone 96
SE - Svezia 83
IN - India 70
CA - Canada 59
MX - Messico 51
ID - Indonesia 44
AR - Argentina 43
NL - Olanda 39
EE - Estonia 37
BD - Bangladesh 35
IQ - Iraq 29
ZA - Sudafrica 28
BE - Belgio 26
CO - Colombia 24
CZ - Repubblica Ceca 22
EC - Ecuador 22
ES - Italia 19
MA - Marocco 18
MY - Malesia 17
LT - Lituania 14
PK - Pakistan 14
PY - Paraguay 13
SA - Arabia Saudita 13
VE - Venezuela 12
IE - Irlanda 11
IR - Iran 11
UZ - Uzbekistan 11
PH - Filippine 10
AE - Emirati Arabi Uniti 9
AT - Austria 8
CL - Cile 8
ET - Etiopia 8
KE - Kenya 8
RO - Romania 8
EG - Egitto 7
KR - Corea 7
NP - Nepal 7
TN - Tunisia 7
TW - Taiwan 7
UY - Uruguay 7
AL - Albania 6
BG - Bulgaria 6
PT - Portogallo 6
SD - Sudan 6
JM - Giamaica 5
KZ - Kazakistan 5
PS - Palestinian Territory 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AU - Australia 4
EU - Europa 4
LB - Libano 4
LV - Lettonia 4
OM - Oman 4
BH - Bahrain 3
BO - Bolivia 3
HU - Ungheria 3
IL - Israele 3
JO - Giordania 3
KW - Kuwait 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
PA - Panama 3
RS - Serbia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
AF - Afghanistan, Repubblica islamica di 2
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CH - Svizzera 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
PE - Perù 2
BB - Barbados 1
BW - Botswana 1
CD - Congo 1
CI - Costa d'Avorio 1
DZ - Algeria 1
GN - Guinea 1
HN - Honduras 1
KH - Cambogia 1
MK - Macedonia 1
MT - Malta 1
Totale 12.042
Salva come PNG Salva come JPEG
Città #
Singapore 847
Ashburn 638
Woodbridge 521
San Jose 428
Fairfield 340
Jacksonville 331
Beijing 324
Chandler 324
Houston 312
Santa Clara 289
Ann Arbor 281
Hong Kong 264
Wilmington 139
Dallas 133
Ferrara 132
Ho Chi Minh City 132
Cambridge 113
Seattle 111
Nanjing 110
Warsaw 107
Izmir 100
Tokyo 94
Los Angeles 92
Munich 87
Princeton 81
Hanoi 80
Boardman 67
Lauterbourg 62
Helsinki 61
Dearborn 57
New York 52
Milan 45
São Paulo 41
Nanchang 37
Shanghai 37
Council Bluffs 36
Shenyang 35
San Diego 33
Turku 33
London 30
Tianjin 30
Changsha 29
Mexico City 28
Brussels 26
Buffalo 26
Orem 24
Bologna 23
Chennai 23
Montreal 23
Jakarta 22
Poplar 21
Da Nang 20
The Dalles 20
Bremen 19
Frankfurt am Main 19
Brno 18
Brooklyn 18
Chicago 18
Hefei 18
Denver 17
Jiaxing 17
Boston 16
Hebei 16
Haiphong 15
Moscow 15
Ningbo 15
Orange 15
Phoenix 15
Stockholm 15
Addison 14
Jinan 13
Norwalk 13
San Francisco 13
Toronto 13
Atlanta 12
Manchester 12
San Mateo 12
Amsterdam 11
Dublin 11
Redwood City 11
Augusta 10
Mountain View 10
Philadelphia 10
Auburn Hills 9
Baghdad 9
Brasília 9
Curitiba 9
Dong Ket 9
Guangzhou 9
Hillsboro 9
Johannesburg 9
Kraków 9
Ninh Bình 9
Quito 9
Tashkent 9
Washington 9
Kuala Lumpur 8
Paris 8
Rio de Janeiro 8
Addis Ababa 7
Totale 7.930
Salva come PNG Salva come JPEG
Nome #
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 272
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 245
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 238
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 235
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 210
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 208
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 205
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 203
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 203
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 193
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 191
Mutual communication of envelope glycoproteins of paramixoviruses 188
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 186
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 186
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 186
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 186
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 185
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 180
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 178
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 178
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 174
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 174
Substrate binding to 6-phosphogluconate dehydrogenase 173
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 172
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 169
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 168
Biochemical study in adult population with stroke in Ferrara, Fabry disease 166
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 165
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 163
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 160
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 160
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 158
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 152
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 150
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 148
Active myeloperoxidase: a promising biomarker to differentiate “acute” and “low-grade” peri-prosthetic joint infections from aseptic failures 147
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 147
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 147
Domain structure of the hemagglutinin-neuraminidase from sendai virus 142
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 141
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 138
Purification of transglutaminase enzyme from L. infantum promastigotes 137
Studies of Interaction between Sendai Virus Envelope Glycoproteins (HN ad F) by Syntetic peptides derived from the HR2 Region of the F Protein 135
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 135
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 132
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 131
Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high energy intermediate and transition state analogues 130
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 129
null 128
MMP-9 isoforms in serum of Multiple Sclerosis patients 127
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 126
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 126
Fluids administration modulate the matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO) activities and inflammatory neutrophils response 123
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 123
Differential pathogenicity and lethality of bubonic plague (1720–1945) by sex, age and place 122
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 121
Thermodynamic characterization of 6-phosphogluconate dehydrogenase ternary complex 121
Influence of 6-aminonicotinamide (6AN) on Leishmania promastigotes evaluated by metabolomics: beyond the pentose phosphate pathway 120
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 119
Enzymatic activation of NCX4016, a nitrate ester derivative of Aspirin 116
Unfording and limited proteolysis of the hemagglutinin-neuraminidase from sendai virus 110
null 110
Effects of anticoagulants on the activity of gelatinases 110
Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases 106
Partial unfolding of the hemagglutinin-neuraminidase from sendai virus 105
Effects of anticoagulants on the activity of gelatinases 105
null 104
Matrix Metalloprotease-9 activity detected in body fluids is the result of two different enzyme forms 103
Synthetic peptides corresponding to the heptad repeat region of sendai virus fusion protein bind to the hemagglutinin-neuraminidase 102
Gelatinase A (MMP-2) and B (MMP-9): their active forms as biomarkers in multiple sclerosis 102
Xenobiotics biodegradation: recombinant DCM dehalogenase from alcaligenes xylosoxydans 101
Fluids administration can modulate inflammatory neutrophils response and MMP-9 activity: an in vitro study 100
null 97
The influence of different replacement solutions on neutrophils response 96
Vaginal Lactoferrin Administration Decreases Oxidative Stress in the Amniotic Fluid of Pregnant Women: An Open-Label Randomized Pilot Study 89
Modulation of metalloproteinase-9 (MMP-9) by its specific tissue inhibitor (TIMP1) 88
null 88
Chemical and biological versatility of pyrazolo[3,4-d]pyrimidines: one scaffold, multiple modes of action 87
inhibition of sendai virus fusion protein by interaction synthetic peptides derived F protein and hemagglutinin-neuraminidase 86
Lactoferrin administration prior to genetic amniocentesis dampens the intraamniotic inflammatory response 80
Effects of two different strategies of fluid administration on inflammatory mediators, plasma electrolytes and acid/base disorders in patients undergoing major abdominal surgery: a randomized double blind study. 80
pH dependent structural changes of the hemagglutinin-neuraminidase from sendai virus 77
Commentary on the Issue of Leishmania Infection: Focus on Some Pathogenetic, Clinical, and Epidemiological Aspects 59
Influence of different strategies of volume replacement on the activity of metalloproteinases 9 54
null 53
null 49
BACE-1 and ADAM-10 as Potential Peripheral Biomarkers for Alzheimer’s Disease 39
Sex differences in biomarkers: Implications for age-related diseases 30
Sex and Gender in Ageing and Longevity: Highlights from an International Course 4
Totale 12.185
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 55
Totale 51.906
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021302 0 0 0 0 0 0 0 0 0 121 139 42
2021/2022639 21 70 26 21 27 25 19 25 19 71 45 270
2022/2023791 77 66 20 95 134 106 47 69 84 11 52 30
2023/2024407 42 48 16 15 61 40 10 24 17 12 8 114
2024/20251.818 49 42 153 73 216 152 68 98 263 232 276 196
2025/20264.680 502 227 410 610 685 322 655 285 474 510 0 0
Totale 12.185